Clinical Trial: Plant-Derived Cbd/Thc Extracts Safe and Effective for Children with Intractable Epilepsy | NORML
The long-term administration of cannabis-plant derived extracts containing a 50 to 1 ratio of CBD to THC is safe and effective in children with treatment-resistant epilepsy, according to clinical trial data published in the journal Annals of Clinical and Translational Neurology. Canadian researchers assessed the adjunctive use of a proprietary CBD/THC extract (aka TIL-TC150, manufactured by Tilray Inc.) over […]
Clinical Trial: Plant-Derived Cbd/Thc Extracts Safe and Effective for Children with Intractable Epilepsy | The Daily Chronic